Financials
- Market Capitalization 23.77 M
- Employee 40
- Founded 2015
- CEO N/A
- Website www.nextcure.com
- Headquarter Delaware, United States
- FIGI BBG00BTH5153
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.63
ratio cours/chiffre d'affaires
27.98 K
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4537 | BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.61 USD | 0.00% | -1.61% | -12.86% | -40.20% | 24.92 M USD | ||
| 4548 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.44 USD | -1.37% | -13.77% | +6.67% | -8.28% | 24.01 M USD | ||
| 4551 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.73 USD | 0.00% | +7.35% | +5.80% | -64.73% | 23.77 M USD | ||
| 4553 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +9.23% | +16.39% | -46.21% | 23.68 M USD |